Neudle.com: NMDA receptors antagonist of

Neurology Specific Literature Search

Differential
(Click to cross reference)

acute disseminated encephalomyelitis

advances in neurology

adverse drug reaction

alveolar hypoventilation

Alzheimer's disease

Alzheimer's disease, treatment of

AMPA receptor antibodies

amphiphysin antibodies

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, etiology of

amyotrophic lateral sclerosis, treatment of

anti GQ1b IgG antibody

anti Hu antibody

anti MAG antibodies

anti Ri antibody

anticholinesterase

arrhythmia, cardiac

ataxia, cerebellar

ataxia, truncal

autoimmune basal ganglia encephalitis

autoimmune disease

autoimmune encephalopathy

autoimmune epilepsy

automobile accidents

autonomic dysfunction

autonomic neuropathy

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

behavioral disorder, acute

brainstem, lesion of

calcium antagonist

carcinoma of breast

carcinoma of lung

carcinoma of ovary

CAT scan, chest

CAT scan, emission, abnormal

CAT scan, pelvis

central nervous system, infection of

cerebellar degeneration

cerebellar lesion

cerebellitis, autoimmune

cerebral cortex

cerebral embolism

cerebral ischemia

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, pathophysiology

cerebrovascular accident, prevention of

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, time of presentation

choreoathetosis

Clinical Pathologic Conference(C.P.C.)

collapsin response mediator protein 5 IgG

coma, medically induced

contactin associated protein like 2 antibodies

controversies in neurology

creatine phosphokinase(CPK)elevated

cyclophosphamide

cytochrome c oxidase

deep gray nuclei

degenerative diseases of CNS

dementia, reversible

dementia, treatment of

demyelinating disease

dermatomyositis

diagnostic criteria

differential diagnosis

down-beat nystagmus

DPPX, antibodies

DPPX, antibodies, encephalitis

dura, thickened

dyskinesia, buccal lingual facial

dyskinesia, facial

electroencephalogram

electroencephalogram, abnormalities of

emotional lability

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, clinical picture and treatment of

encephalitis, etiology

encephalitis, paraneoplastic

encephalitis, unilateral

encephalitis, unknown etiology

encephalitis, viral

encephalitis, viral-causes of

encephalomyelitis

encephalomyelitis, autoimmune

encephalopathy, Hashimoto's

encephalopathy, progressive

epidemiology of neurology

extreme delta brush

eye movement, disorders of

face, numbness of

faciobrachial dystonic seizure

fibrinolytic agents

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

gaze palsy, horizontal

glutamic acid decarboxylase, antibody

glycine receptor antibodies

gyrus, abnormal

hallucination, visual

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex encephalitis, recurrent

herpes simplex virus

hippocampus, hyperintense

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

hypoxic encephalopathy

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

inappropriate antidiuretic(A.D.H.)hormone

inborn errors of metabolism, screening

intellectual deficit

intellectual deterioration

internuclear ophthalmoplegia

internuclear ophthalmoplegia, bilateral

ischemic penumbra

Jakob-Creutzfeldt disease

laughing, pathologic

leucine rich glioma inactivated 1 antibodies

level of consciousness

level of consciousness, decreased

life expectancy

limbic encephalitis

lymphoma involving CNS

malignancy screen

malignancy, occult

mediastinum, mass of

memory, defect of recent

memory, impairment of

meningeal enhancement

mental status, abnormal

mesial temporal lobe

monoclonal antibodies

Morvan's fibrillary chorea

motor neuron disease

movement disorder

movement disorder, extrapyramidal

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

multiple sclerosis

myasthenia gravis, paraneoplastic

myasthenic syndrome

myelitis, autoimmune

myelitis, longitudinal

myelitis, transverse, recurrent

nausea and vomiting

neurexin-3 alpha antibodies

neuroendocrinology

neurologic complications

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic disease, multiple

neurologic examination, focal

neurologic signs

neuromuscular junction

neuromyelitis optica (Devic's disease)

neuromyelitis optica, IgG

neuronal cell surface antigen

neuronopathy, sensory

neuroophthalmology

neuropathy, paraneoplastic

neuroprotective agents

neurotransmitter

NMDA antagonist, late onset

NMDA antagonists

noncommunicative

nystagmus, upbeating on upgaze

nystagmus, vertical

old age, neurology of

onconeural antibodies

ophelia syndrome

opsoclonus-myoclonus syndrome

overlap syndrome

pachymeningitis, cranial

paraneoplastic brainstem encephalitis

paraneoplastic cerebellar degeneration

Parkinson disease

Parkinson disease, treatment of

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

peripheral nerve, lesion of

personality change

pleocytosis of cerebrospinal fluid

post herpes simplex encephalitis immune-mediated relapse

postural abnormality

potassium channel antibodies

practice guidelines

precipitating factors

prevention of neurologic disorders

progressive encephalomyelitis with rigidity syndrome

progressive neurologic disorder

psychiatric problems in neurologic disorders

psychosis, acute

psychosis, childhood

psychotic behavior

pupil, abnormality in neurologic disorders

rabies, nervous system involvement with

release phenomena

remote effect of cancer on the nervous system

reversal of sleep wake cycle

reversible neurologic disorder

salivation, excessive

seizure, adult onset

seizure, drug resistance

seizure, intractable

seizure, intractable, treatment of

seizure, psychomotor-temporal lobe

seizure, treatment of

seizure, unknown origin

serologic testing

serologic testing of cerebrospinal fluid

serologic testing, false negative

sexual behavior, disorder of

sleep pathology and physiology

speech disorder

speech disorder, childhood

spinal cord, cervical

spinal cord, lesion of

status epilepticus

status epilepticus, nonconvulsive

steroid responsive encephalopathy

steroid therapy, CNS treatment and complications with

stiff man syndrome

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

stroke, progression of

sweating, abnormality of

symmetric brain lesions

syphilis, neurologic complications with

temporal lobe, lesion

temporal lobe, lesion, bilateral

teratoma, ovarian

testicular teratoma

tissue plasminogen activator, intravenous

tongue, protrusion of

treatment of neurologic disorder

unconsciousness

varicella zoster virus

viral infection

viral infection, CNS

vision, blurred

white matter disease

white matter disease, subcortical

Showing articles 800 to 850 of 1202 << Previous Next >>

Fiddleheads and the International Normalized Ratio
NEJM 338:1550, Bartle,W.R.&Ferland,G., 1998

Rizatriptan (MAXALT) for the Acute Treatment of Migraine & Migraine Recurrence, Rizatriptan 022 Study Grp
Headache 38:281-287, Tuchman,T.J.,et al, 1998

Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Neurol 51:674-681, Hart,R.G.,et al, 1998

Stroke Prevention in Patients with Nonvascular Atrial Fibrillation
Qual Stds Subcom AAN, Neurol 51:671-6731998., , 1998

A Placebo-ControlledCrossover Study of Rizatriptan in the Treatment of Multiple Migraine Attacks
Neurol 52:773-781, Kramer,M.S.,et al, 1998

Acute Therapy for Cluster Headache with Sumatriptan:Findings of a One-Year Long-Term Study
Neurol 51:980-911, Gobel,H.,et al, 1998

Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998

Ropinirole for the Treatment of Early Parkinson Disease
Arch Neurol 55:1211-1216, Sethi,K.D.,et al, 1998

A Pilot Study of Oral Sumatriptan as Intermittent Prophylaxis of Menstruation-Related Migraine
Neurol 51:307-309, Newman,L.C.,et al, 1998

Inappropriate Use of Sumatriptan:Population Based Register and Interview Study
BMJ 316:1352-1353, Gaist,D.,et al, 1998

Pregnancy Outcome Following First Trimester Exposure to Sumatriptan
Neurol 51:581-583, Shuhaiber,S.,et al, 1998

Sumatriptan Injection Reduces Productivity Loss During a Migraine Attack
Arch Int Med 158:1013-1018, Cady,R.C.,et al, 1998

Calcium Antagonists in Patients with Aneurysmal Subarachnoid Hemorrhage
Neurol 50:876-883, Feigin,V.L.,et al, 1998

Prognosis of Patients with Symptomatic Vertebral or Basilar Artery Stenosis
WASID Study Group, Stroke 29:1389-13921998., , 1998

Cost-Effectiveness of Anticoagulation in Nonrheumatic A Fib in the Primary Prevention of Ischemic Stroke
Stroke 29:1827-1832, Lightowlers,S.&McGuire,A., 1998

Fixed Minidose Warfarin & Aspirin Alone & in Comb vs Adjusted-Dose Warfarin for Stroke Prevent in Atrial Fib
Arch Int Med 158:1513-1521, 14871998., Gullov,A.L.,et al, 1998

Pts with Nonvalvular Fib at Low Risk of Stroke During Trtm with Aspirin
Stroke Prevent in A Fib, SPAF III Cmte for Stroke Prevent, JAMA 279:1273-1277998., , 1998

Transesoph Echocardiogr Correl of Thromboembolism in High-Risk Pts with Nonvalv Atrial Fib
Ann Int Med 128:639-647, 6851998., Chan,K.L.,et al, 1998

Differences in Medical & Surgical Therapy for Stroke Prevention Between Experts in N. America & Europe
Stroke 29:339-345, Masuhr,F.,et al, 1998

Acetylcholine Receptor Antibodies in the Lambert-Eaton Myasthenic Syndrome
Neurol 50:470-475, Katz,J.S.,et al, 1998

Subcutaneous Apomorphine in Parkinson's Disease
Effective Yet Underused, BMJ 316:6411998., , 1998

Mobile Aortic Atheroma & Systemic Emboli:Efficacy of Anticoag & Influence of Plaque Morphol on Recurr Stroke
J Am Coll Cardiol 31:134-138, Dressler,F.A.,et al, 1998

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
JAMA 279:657-662, 7021998., Hylek,E.M.,et al, 1998

Stiff-Leg Syndrome:A Focal Form of Stiff-Man Syndrome
Ann Neurol 43:400-403, Saiz,A.,et al, 1998

Ischemic Colitis and Sumatriptan Use
Arch Int Med 158:1946-1948, Knudsen,J.F.,et al, 1998

Comparison of an Anticoagulation Clinic With Usual Medical Care: Anticoagulation Control, Patient Outcomes, and Health Care Costs
Arch Int Med 158:1641-1647, Chiquette,E.,et al, 1998

Multiple Intracerebral Hemorrhages and Vasospasm Following Antimigrainous Drug Abuse
Headache 38:478-480, Nighoghossian,N.,et al, 1998

Preventing Stroke Recurrence in Patients with Patent Foramen Ovale: Antithrombotic Therapy, Foramen Closure, or Therapeutic Abstention? A Decision Analytic Perspective
Am Heart J 135:532-541, Nendaz,M.R.,et al, 1998

Medically Induced Gingival Hyperplasia
Mayo Clin Proc 73:1196-1199, Meraw,S.J. &Sheridan,P.J., 1998

Sumatriptan Nasal Spray for Acute Treatment of Migraine, Results of Two Clin Studies
Neurol 49:1225-1230, 11931997., Ryan,R.,et al, 1997

Optimizing the Dose of Zolmitriptan (Zomig, *311C90) for the Acute Treatment of Migraine
Neurol 49:1210-1218, 11931997., Rapoport,A.M.,et al, 1997

Clinical Efficacy and Tolerability of 2. 5Mg Zolmitriptan for the Acute Treatment of Migraine
Neurol 49:1219-1225, Solomon,G.D.,et al, 1997

Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine
Neurol 49:1485-1490, Mathew,T.,et al, 1997

Clinicopath Conf
Rocky Mountain Spotted Fever with Meningoencephalomyelitis, Vasculitis and Focal Myocarditis, Case 3, -17,NEJM 337:1149-1156,1997., 1997

Sumatriptan for Migraine Attacks in Children:A Randomized Placebo-Controlled Study
Neurol 48:1100-1103, Hamalainen,M.L.,et al, 1997

Safety and Efficacy of Pramipexole in Early Parkinson Disease
Parkinson Study Group, JAMA 278:125-1301997., , 1997

Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997

Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997

Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997

Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997

Ventricular Dysfunction and the Risk of Stroke After Myocardial Infarction
NEJM 336:251-257, Loh,E.,et al, 1997

Clinical Characteristics & Mgt of Acute Stroke in Pts with Atrial Fib Admitted to US Univ Hosp
Neurol 48:1598-1604, Albers,G.W.,et al, 1997

Does Paroxysmal Atrial Fibrillation Confer a Paroxysmal Thromboembolic Risk
Lancet 349:1565-1566, Lip,G.Y.H., 1997

Management of Anticoagulation Before and AFter Elective Surgery
NEJM 336:1506-1511, Kearon,C.&Hirsh,J., 1997

Thromboembolism Prophylaxis in Chronic Atrial Fibrillation:Practice Patterns in Community & Tertiary-Care Hosp
Stroke 28:72-76, Munschauer,F.E.,et al, 1997

Continuous Bromocriptine Therapy in Menstrual Migraine
Neurol 48:101-102, Herzog,A.G., 1997

Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997

Characteristics and Determinants of Sumatriptan-Associated Chest Pain
Arch Neurol 54:1387-1392, Ottervanger,J.P.,et al, 1997

Warfarin Use Among Patients with Atrial Fibrillation
Stroke 28:2382-2389, Brass,L.M.,et al, 1997

A Randomized Trial of Anticoagulants Vs Aspirin After Cerebral Ischemia of Presumed Arterial Origin
SPIRIT Study Group, Ann Neurol 42:857-8651997., , 1997

Showing articles 800 to 850 of 1202 << Previous Next >>